Today, our screeners were at work and below is a list of 4 HealthTech Stocks up over 53% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Bellerophon Therapeutics Inc., BLPH
Summary: Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton, New Jersey.
Recent BLPH Stock Price (approx 10:00am EST.): $2.37
Previous Close for BLPH Stock: $2.29
Percentage Price Change Past 10 Days for BLPH stock: +160%
What is the forecast for BLPH stock? Here are 3rd party ratings for BLPH stock:
|
What’s the sentiment on the street for BLPH stock? Current ratings compiled by TipRanks.com)
|
Click for the BLPH stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Coeptis Therapeutics Holdings Inc., COEP
Summary: Coeptis Therapeutics Holdings Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer. Coeptis Therapeutics Holdings Inc., formerly known as Bull Horn Holdings Corp., is based in WEXFORD, Pa.
Recent COEP Stock Price (approx 10:00am EST.): $1.95
Previous Close for COEP Stock: $1.94
Percentage Price Change Past 10 Days for COEP stock: +56%
What is the forecast for COEP stock? Here are 3rd party ratings for COEP stock:
|
What’s the sentiment on the street for COEP stock? Current ratings compiled by TipRanks.com)
|
Click for the COEP stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Pardes Biosciences Inc. is a clinical-stage biopharmaceutical company. It discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company's lead product candidate includes PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences Inc., formerly known as FS Development Corp. II, is based in SAN FRANCISCO, Calif.
Recent PRDS Stock Price (approx 10:00am EST.): $2.07
Previous Close for PRDS Stock: $1.93
Percentage Price Change Past 10 Days for PRDS stock: +54%
What is the forecast for PRDS stock? Here are 3rd party ratings for PRDS stock:
|
What’s the sentiment on the street for PRDS stock? Current ratings compiled by TipRanks.com)
|
Click for the PRDS stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Black Diamond Therapeutics Inc., BDTX
Summary: Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.
Recent BDTX Stock Price (approx 10:00am EST.): $2.11
Previous Close for BDTX Stock: $2.02
Percentage Price Change Past 10 Days for BDTX stock: +53%
What is the forecast for BDTX stock? Here are 3rd party ratings for BDTX stock:
|
What’s the sentiment on the street for BDTX stock? Current ratings compiled by TipRanks.com)
|
Click for the BDTX stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.